We are live on ! Find out more
TG

TLP Group Portfolio holdings

AUM $6.61M
1-Year Est. Return 12.46%
This Fund
S&P 500
This Quarter Est. Return
+18.07%
1 Year Est. Return
-12.46%
3 Year Est. Return
+42.65%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$144M
AUM Growth
-$14.9M
Cap. Flow
-$292K
Cap. Flow %
-0.2%
Top 10 Hldgs %
64.22%
Holding
794
New
229
Increased
159
Reduced
207
Closed
182

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$3.53M
2
PFE icon
Pfizer
PFE
+$2.63M
3
MRK icon
Merck
MRK
+$1.44M
4
AMGN icon
Amgen
AMGN
+$1.26M
5
LLY icon
Eli Lilly
LLY
+$976K

Top Sells

Rank Stock Value
1
AIMT
Aimmune Therapeutics
AIMT
+$30.2M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$2.96M
3
GM icon
General Motors
GM
+$484K
4
DSKEW
Daseke, Inc. Warrant
DSKEW
+$417K
5
TSLA icon
Tesla
TSLA
+$395K

Sector Composition

Rank Sector Weight
1 Healthcare 8.73%
2 Financials 6.69%
3 Consumer Discretionary 5.75%
4 Industrials 4.37%
5 Technology 3.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
26
PUT
Pfizer
PFE
$142B
$436K 0.3%
698,591
+276,991
+66% +$9.44M
OVV icon
27
Ovintiv
OVV
$17.2B
$414K 0.29%
6,209
-3,256
-34% -$192K
DHR icon
28
Danaher
DHR
$134B
$400K 0.28%
4,863
+4,688
+2,679% +$381K
L icon
29
Loews
L
$23.7B
$397K 0.28%
7,932
+1,711
+28% +$84.5K
FIS icon
30
Fidelity National Information Services
FIS
$20.8B
$396K 0.27%
4,212
+1,132
+37% +$106K
FXI icon
31
iShares China Large-Cap ETF
FXI
$4.29B
$395K 0.27%
8,564
– –
RTN
32
DELISTED
Raytheon Company
RTN
$394K 0.27%
2,098
+2,067
+6,668% +$385K
ADM icon
33
Archer Daniels Midland
ADM
$41.7B
$393K 0.27%
9,805
+2,761
+39% +$114K
TMO icon
34
Thermo Fisher Scientific
TMO
$214B
$393K 0.27%
2,072
+1,999
+2,738% +$383K
MDT icon
35
Medtronic
MDT
$105B
$391K 0.27%
4,846
+1,171
+32% +$93.8K
META icon
36
Meta Platforms (Facebook)
META
$1.54T
$390K 0.27%
2,212
+1
+0% +$177
SPG icon
37
Simon Property Group
SPG
$73B
$390K 0.27%
2,272
-415
-15% -$67.4K
BC icon
38
Brunswick
BC
$5.14B
$385K 0.27%
6,964
+6,642
+2,063% +$361K
APD icon
39
Air Products & Chemicals
APD
$65.7B
$383K 0.27%
2,332
+401
+21% +$63.9K
AME icon
40
Ametek
AME
$55.1B
$382K 0.26%
5,267
+5,249
+29,161% +$366K
TRIP icon
41
TripAdvisor
TRIP
$1.56B
$381K 0.26%
+11,047
New +$399K
GS icon
42
Goldman Sachs
GS
$317B
$379K 0.26%
1,487
+795
+115% +$195K
ICE icon
43
Intercontinental Exchange
ICE
$80.8B
$375K 0.26%
+5,313
New +$365K
NTAP icon
44
NetApp
NTAP
$32.3B
$374K 0.26%
+6,763
New +$339K
J icon
45
Jacobs Solutions
J
$15.5B
$372K 0.26%
6,814
+695
+11% +$35.6K
SNPS icon
46
Synopsys
SNPS
$71.6B
$371K 0.26%
4,353
+585
+16% +$50.6K
BGC icon
47
BGC Group
BGC
$5.54B
$368K 0.26%
+37,878
New +$382K
BIO icon
48
Bio-Rad Laboratories Class A
BIO
$8.36B
$365K 0.25%
1,530
+1,501
+5,176% +$364K
CNQ icon
49
Canadian Natural Resources
CNQ
$98.2B
$364K 0.25%
20,812
-6,626
-24% -$111K
TEAM icon
50
Atlassian
TEAM
$20.7B
$364K 0.25%
+8,005
New +$373K
1
2
3 4 5

Similar funds

LAM
Lyxor Asset Management New York $8.58M AUM 3.07% 1-Year Est. Return
SPCP
Snow Park Capital Partners New York $3.17M AUM 3.35% 1-Year Est. Return
GZ
George Zachary $2.34M AUM 5.28% 1-Year Est. Return
RGNCM
R.G. Niederhoffer Capital Management New York $11.3M AUM
FCM
Force Capital Management New York $11.4M AUM 5.65% 1-Year Est. Return
DCM
Dynamic Capital Management St. Helier, Jersey $12M AUM 0.65% 1-Year Est. Return
DAL
David A. Lorber $1.11M AUM 4.74% 1-Year Est. Return
SAM
Sentinel Asset Management Montpelier, Vermont $868K AUM 45.44% 1-Year Est. Return

TLP Group's Q4 2017 Portfolio in Review

As of Q4 2017, TLP Group held 794 positions worth $144M, down 9.4% from $159M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

TLP Group's Q4 2017 filing shows 229 new, 159 increased, 207 reduced and 182 closed positions. Its largest new stake was iShares Biotechnology ETF: 4,800 shares worth $512K. The largest sale was Aimmune Therapeutics, an estimated $30.2M.

By sector, the portfolio is most concentrated in Healthcare at 8.7% of assets, up from 4.8% a quarter earlier, followed by Financials and Consumer Discretionary.

  • TLP Group's largest Q4 2017 buy was iShares Biotechnology ETF: 4,800 shares worth $512K.
  • TLP Group added most to iShares Russell 2000 ETF in Q4 2017, an estimated $3.53M increase.
  • TLP Group's biggest Q4 2017 reduction was Aimmune Therapeutics, cutting an estimated $30.2M.
  • TLP Group fully exited Daseke, Inc. Warrant in Q4 2017, selling an estimated $417K.
  • TLP Group's ten largest holdings make up 64% of its $144M portfolio in Q4 2017.
  • TLP Group opened 229 new positions and closed 182 in Q4 2017.
  • TLP Group's portfolio value fell 9.4% quarter-over-quarter to $144M.

Based on TLP Group's 13F filing for Q4 2017, filed 14 Feb 2018.